DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage

Oncolytic virotherapy is a promising therapeutic strategy that uses replication-competent viruses to selectively destroy malignancies. However, the therapeutic effect of certain oncolytic viruses (OVs) varies among cancer patients. Thus, it is necessary to overcome resistance to OVs through rational...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xiao, Liang, Jiankai, Huang, Chunlong, Li, Kai, Xing, Fan, Zhu, Wenbo, Lin, Ziqing, Xu, Wencang, Wu, Guangen, Zhang, Jifu, Lin, Xi, Tan, Yaqian, Cai, Jing, Hu, Jun, Chen, Xueqin, Huang, Youwei, Qin, Zixi, Qiu, Pengxin, Su, Xingwen, Chen, Lijun, Lin, Yuan, Zhang, Haipeng, Yan, Guangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194050/
https://www.ncbi.nlm.nih.gov/pubmed/30337542
http://dx.doi.org/10.1038/s41467-018-06771-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194050/
https://www.ncbi.nlm.nih.gov/pubmed/30337542
http://dx.doi.org/10.1038/s41467-018-06771-4

Ejemplares similares